Related Experiment Video

Updated: Jun 12, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

miRNAs as therapeutic targets in ischemic heart disease

Robert J A Frost1, Eva van Rooij

  • 1Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-9148, USA.

Journal of Cardiovascular Translational Research
|June 19, 2010
PubMed

Insights

Ischemic heart disease damages heart tissue, causing remodeling that worsens function. Modulating microRNAs (miRNAs) offers a promising therapeutic strategy to improve outcomes for patients with this condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Ischemic heart disease results from reduced blood supply, leading to heart tissue damage and secondary remodeling.
  • This remodeling, including fibrosis and myocyte hypertrophy, impairs cardiac function and increases arrhythmia risk.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in post-myocardial infarction remodeling.
  • To explore miRNA modulation as a therapeutic strategy for ischemic heart disease.

Main Methods:

  • Literature review of studies on microRNAs in myocardial infarction and cardiac remodeling.
  • Analysis of miRNA regulatory mechanisms in response to cardiac injury.

Main Results:

  • MicroRNAs are identified as key regulators of gene expression during post-myocardial infarction remodeling.
  • Specific miRNAs play critical roles in processes like fibrosis and hypertrophy.

Conclusions:

  • MicroRNA modulation presents a novel therapeutic avenue for treating ischemic heart disease.
  • Targeting miRNAs could potentially improve cardiac function and reduce adverse remodeling after myocardial infarction.

More Related Videos

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...